The Challenge of Drug-Induced Aseptic Meningitis Revisited

被引：46

作者：

Moris, German ^{[1
]}

Carlos Garcia-Monco, Juan ^{[2
]}

机构：

[1] Hosp Univ Cent Asturias, Dept Neurol, Oviedo, Asturias, Spain

[2] Hosp Galdakao Usansolo, Dept Neurol, Galdakao 48960, Vizcaya, Spain

来源：

JAMA INTERNAL MEDICINE | 2014年 / 174卷 / 09期

关键词：

D O I：

10.1001/jamainternmed.2014.2918

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1511 / 1512

页数：3

共 6 条

[1]

Emani M K, 2013, J Oncol Pharm Pract, V19, P178, DOI 10.1177/1078155212447973

[2] Infliximab-induced headache and infliximab-induced meningitis: Two ends of the same spectrum? [J].

Hegde, N ;

Gayomali, C ;

Rich, MW .

SOUTHERN MEDICAL JOURNAL, 2005, 98 (05) :564-566

[3] Efalizumab-induced aseptic meningitis [J].

Kluger, N. ;

Girard, C. ;

Gonzalez, V. ;

Guillot, B. ;

Bessis, D. .

BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (01) :189-191

[4] The challenge of drug-induced aseptic meningitis [J].

Moris, G ;

Garcia-Monco, JC .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (11) :1185-1194

[5] Pemetrexed induced aseptic meningitis [J].

Shah, Binay K. ;

O'Keefe, Sandra .

ACTA ONCOLOGICA, 2012, 51 (03) :399-U132

[6] Lamotrigine and aseptic meningitis [J].

Simms, Kelley M. ;

Kortepeter, Cindy ;

Avigan, Mark .

NEUROLOGY, 2012, 78 (12) :921-927

← 1 →